The efficacy and safety of anlotinib treatment for advanced lung cancer.

Shao, Lan; Wang, Wenxian; Song, Zhengbo; Zhang, Yiping

Shao, Lan; Wang, Wenxian; Song, Zhengbo; Zhang, Yiping.

Afiliação

Shao L; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People's Republic of China.
Wang W; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People's Republic of China.
Song Z; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People's Republic of China.
Zhang Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People's Republic of China.

Onco Targets Ther ; 12: 6549-6554, 2019.

Article em En | MEDLINE | ID: mdl-31616163

Palavras-chave

VEGF; anlotinib; efficacy; lung cancer; safety

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2019 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google